The diagnostic potential of NOX4 is rooted in its abnormal expression in cancer tissues, including but not limited to breast cancer, lung cancer, colorectal cancer, and pancreatic cancer [10–13]. This evidence concerns the gene NOX4 and breast carcinoma.